Skip to content

Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis

Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04451213
Enrollment
15
Registered
2020-06-30
Start date
2021-08-23
Completion date
2022-12-23
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Brief summary

CF is a complex, inherited illness that can affect many organs of the body. The investigators have found that some patients with CF have reported more problems with memory than would be expected at their age and that patients appear to be using memory strategies to overcome memory loss. The investigators intend to objectively test memory and examine MRI images of the brain of patients with CF.

Detailed description

Patients with CF have several potential risk factors which may predispose them to memory problems. Because the CF population has historically only been young, this is not something that has been focused on. No research has currently identified whether patients with CF have a much earlier risk of developing cognitive impairment or how CF impacts on the brain. There has not previously been work in this area of CF and the investigators are in a unique position with the Cardiff University Brain Research Imaging Centre (CUBRIC) and its expertise to be able to perform Magnetic Resonance Imagining (MRI) scans and neurocognitive testing on patients with CF for the first time.

Interventions

DIAGNOSTIC_TESTMRI head

MRI head

Sponsors

Cardiff University
CollaboratorOTHER
Cardiff and Vale University Health Board
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or Female, aged greater or equal to 30 years * A diagnosis of CF * Primary school education or above * Able to provide informed consent

Exclusion criteria

* Contraindications to MRI as found on the CUBRIC screening form (including presence of indwelling metal devices/clips) * Existing neurological disease affecting cognition (including stroke and traumatic brain injury) * Existing diagnosis of dementia documented in medical notes * Vascular complications of diabetes * Requiring supplemental oxygen -long term or overnight * Hepatic failure * Overt psychiatric disorders * Past or present alcohol or recreational drug misuse * Pregnancy * Current infection Smoker

Design outcomes

Primary

MeasureTime frame
Objective memory scoresup to one year

Secondary

MeasureTime frameDescription
MRI headup to one yearthe investigators will acquire structural and functional MRI data at 3T to explore brain health of CF patients compared to control data. Structural MRI will include T1 and T2 weighted anatomical images for group comparisons of brain morphology (volume, cortical thickness). T1 weighted images will also be used as reference images for all other MRI parameters.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026